A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical ...

A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.

Researchers have found that the way DNA is packaged in cells can directly impact how fast DNA itself is copied during cell division. They discovered that DNA packaging sends signals through an unusual ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Novel method identified protein degraders that target Pin1, a protein involved in pancreatic cancer development.

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins.

There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, ...